Objective. Proliferating cell nuclear antigen (PCNA), one of the target antigen recognized by lupus sera, has been reported to be present as a subnuclear multi-peptide complex. But autoantibodies reacting with components of PCNA complex are poorly understood. To study the specificity of those autoantibodies, immunoreactivities of autoimmune sera against purified PCNA antigen were studied. Methods. PCNA antigens were purified from rabbit thymus extract by affinity column using murine monoclonal antibodies (mAbs) to PCNA, TOB7, TO17 and TO30. Immunoreactivities of autoimmune sera against purified PCNA were analyzed by WB. Results. PCNA antigen purified by serum AK predominantly showed a 34 kD band specific for PCNA in SDS-PAGE. When antigens were purified by anti-PCNA mAb TOB7 and TO30 which are known to be targeting different epitopes on PCNA antigen, SDS-PAGE analysis showed various mol. wt of proteins in addition to the 34 kD PCNA while both AK and mAbs reacted only with 34 kD PCNA in WB. In WB using PCNA purified by TOB7, various immunoreactivities were observed at 150, 66, 58, 48, 45, 37, 32 and 16 kDa in sera from patients with connective tissue diseases. Conclusions. These results suggested that many of the proteins copurified with PCNA were also targets of autoimmune responses and these autoantibody experssion may be induced through antigen-driven mechanisms.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
proliferating cell nuclear antigen
PCNA affinity purified by antibodies from patient serum AK
PCNA purfied by mAb TO30
PCNA purified by mAb TOB7
systemic lupus erythematosus
Tan EM (1989) Adv. Immunol. 44: 93–151
Query CC & Keene JD (1987) Cell 51: 211–220
Tan EM, Chan EKL, Sullivan KF & Rubin RL (1988) Clin. Immunol. Immunopathol. 47: 121–141
Miyachi K, Fritzler MJ & Tan EM (1978) J. Immunol. 121: 2228–2234
Fritzler MJ, McCarty GA, Ryan JP & Kinsella TD (1983) Arthritis Rheum. 26: 140–145
Bravo R, Frank R, Blundell PA & MacDonald-Bravo H (1987) Nature 326: 515–517
Pan Z, Chen M & Hurwitz J (1993) Proc. Natl. Acad. Sci. USA 90: 6–10
Xiong Y Zhang H & Beach D (1992) Cell 71: 505–514
Li R, Waga S, Hannon GJ, Beach D & Stillman B (1994) Nature 371: 534–537
Smith ML, Chen IT, Zhan Q, Bae I, Chen CY, Gilmer TM, Kastan MB, O'Connor PM & Fornace AJJr (1994) Science 266: 1376–1380
Li Y, Jenkins CW, Nichols MA & Xiong Y (1994) Oncogene 9: 2261–2268
Takeuchi K, Kawakami I, Takasaki Y & Hashimoto H (1995) Arthritis Rheum. 38: S212
Sakamoto M, Takasaki Y, Yamanaka K, Kodama A, Hashimoto H & Hirose S (1989) Arthritis Rheum. 32: 1554–1562
Takasaki Y, Ohgaki M, Kodama A, Ogata K, Hashimoto H & Shirai T, Hirose H (1990) J. Immunol. Methods 132: 227–237
Roos G, Landberg G, Huff JP, Houghten R, Takasaki Y & Tan EM (1993) Lab. Invest. 68: 204–210
About this article
Cite this article
Takeuchi, K., Kaneda, K., Kawakami, I. et al. Autoantibodies recognizing proteins copurified with PCNA in patients with connective tissue diseases. Molecular Biology Reports 23, 243–246 (1996). https://doi.org/10.1007/BF00351175
- proliferating cell nuclear antigen
- systemic lupus erythematosus